InsiderTrades.com logo

NDRA Insider Trading

Insider Ownership Percentage: 10.00%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

ENDRA Life Sciences Insider Trading History Chart

This chart shows the insider buying and selling history at ENDRA Life Sciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

ENDRA Life Sciences Share Price & Price History

Current Price: $5.50
Price Change: ▼ Price Decrease of -0.46 (-7.72%)
As of 12/4/2025 05:00 PM ET

This chart shows the closing price history over time for NDRA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

ENDRA Life Sciences Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/27/2024Group Ag UbsMajor ShareholderBuy106$19.25$2,040.504,171View SEC Filing Icon  
5/18/2023Michael Milos ThorntonCTOBuy8$2,887.50$23,100.0019View SEC Filing Icon  
5/2/2023Anthony DigiandomenicoDirectorBuy47$2,100.00$98,700.0058View SEC Filing Icon  
12/9/2022Michael Milos ThorntonCTOBuy0$5,950.00$0.0010View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for ENDRA Life Sciences (NASDAQ:NDRA)

1.19% of ENDRA Life Sciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

ENDRA Life Sciences Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/8/2022Raymond James & Associates70,854$49K0.0%N/A0.168%Search for SEC Filing on Google Icon
8/16/2021State Street Corp60,300$0.13M0.0%N/A0.145%Search for SEC Filing on Google Icon
8/16/2021Goldman Sachs Group Inc.47,709$0.10M0.0%N/A0.114%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
ENDRA Life Sciences logo
ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.
Read More on ENDRA Life Sciences

Today's Range

Now: $5.50
Low: $5.08
High: $5.83

50 Day Range

MA: $5.85
Low: $4.30
High: $8.12

52 Week Range

Now: $5.50
Low: $2.90
High: $11.96

Volume

386,484 shs

Average Volume

66,835 shs

Market Capitalization

$4.13 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of ENDRA Life Sciences?

ENDRA Life Sciences' top insider investors include:
  1. Group Ag Ubs (Major Shareholder)
Learn More about top insider investors at ENDRA Life Sciences.